Editor-in-Chief İlkay Küçükgüzel Associate Editor Esra Tatar Online ISSN 2630-6344 Publisher Marmara University Frequency Bimonthly (Six issues / year) Abbreviation J.Res.Pharm. Former Name Marmara Pharmaceutical Journal
Marmara Pharmaceutical Journal 2016 , Vol 20 , Issue 2
Radioactive Permeability Studies of Doxycycline Hyclate from Microemulsion and Solution
Derya ILEM-OZDEMIR1, Evren GUNDOGDU1, Meliha EKINCI1, Makbule ASIKOGLU1
1Faculty of Pharmacy, Department of Radiopharmacy, Ege University, Bornova, Izmir, Turkey DOI : 10.12991/mpj.201620065652 Doxycycline Hyclate (DOX) is an antibacterial drug which is member of the second tetracycline group and the absorption of DOX is reduced about 20% in the presence of skimmed milk. Therefore new drug delivery system can be advisable for DOX to reduce the food and drug interaction and improve the bioavailability. The aim of the present study is to prepare a microemulsion system of DOX which could result in reducing in food interaction and an improvement of oral bioavailability by increasing the drug"s permeability. For this purposes, DOX was radiolabeled with 99mTc. Radiochemical purity was determined with radioactive thin layer chromatography (RTLC ) studies. Permeability of DOX from 99mTc-DOX solution (99mTc-DOX-S) and 99mTc-DOX loaded microemulsion (99mTc-DOX-M) was investigated with in vitro cell culture studies by using human colonic adenocarcinoma cell line (Caco-2). The radioactivity of 99mTc-DOX-M for the apical to basolateral direction (Papp (A→B)) and basolateral to apical direction (Papp (B→A)) were found higher than 99mTc-DOX-S. Based on the in vitro cell culture studies, this dosage form is a promising formulation as an alternative for oral drug delivery of DOX. Keywords : Doxycycline Hyclate, Permeability, Caco-2, Microemulsion, 99mTc
Marmara University